Apixaban and Epipen drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Apixaban (apixaban) and Epipen (epinephrine). Common drug interactions include asthma among females and cardiac arrest among males.
The phase IV clinical study analyzes what interactions people have when they take Apixaban and Epipen. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.
What is Apixaban?
Apixaban has active ingredients of apixaban. It is often used in blood clots. eHealthMe is studying from 60,351 Apixaban users. Check the latest studies of Apixaban.
What is Epipen?
Epipen has active ingredients of epinephrine. It is often used in anaphylaxis. eHealthMe is studying from 23,760 Epipen users. Check the latest studies of Epipen.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
27 people who take Apixaban and Epipen together, and have interactions are studied.

What are the common drug interactions of Apixaban and Epipen, by gender? *:
female:
- Asthma
- Pain in extremity
- Fatigue (feeling of tiredness)
- Heart rate increased
- Blood pressure decreased
- Blood pressure increased
- Disorientation (disability in which the senses of time, direction, and recognition of people and places)
- Dizziness
- Dyspnoea (difficult or laboured respiration)
- Flushing (the warm, red condition of human skin)
male:
- Cardiac arrest
- Device failure
- Cardiac failure
- Lung transplant
- Pulmonary hypertension (increase in blood pressure in the lung artery)
- Right ventricular failure (right half of the heart fails to work)
- Dyspnoea (difficult or laboured respiration)
- Hypertension (high blood pressure)
- Swelling face
- Decreased appetite
What are the common drug interactions of Apixaban and Epipen, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Asthma
- Blood pressure decreased
- Blood pressure increased
- Disorientation (disability in which the senses of time, direction, and recognition of people and places)
- Dizziness
- Dyspnoea (difficult or laboured respiration)
- Fatigue (feeling of tiredness)
- Flushing (the warm, red condition of human skin)
- Forced expiratory volume decreased (decreased lung expired air volume)
- Headache (pain in head)
40-49:
- Cardiac failure
- Lung transplant
- Pulmonary hypertension (increase in blood pressure in the lung artery)
- Right ventricular failure (right half of the heart fails to work)
50-59:
- Asthma
- Pain in extremity
- Arthralgia (joint pain)
- Arthropathy
- Asthenia (weakness)
- Back pain
- Bone pain
- Carpal tunnel decompression
- Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
- Fatigue (feeling of tiredness)
60+:
- Dyspnoea (difficult or laboured respiration)
- Hypertension (high blood pressure)
- Swelling face
- Decreased appetite
- Fall
- Head injury
- Muscular weakness (muscle weakness)
- Weight decreased
- Pneumonia
- Sepsis (a severe blood infection that can lead to organ failure and death)
What are the existing conditions these people have? *
- Stress And Anxiety: 8 people, 29.63%
- Lower Respiratory Tract Infection: 8 people, 29.63%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 29.63%
- Allergic Rhinitis: 8 people, 29.63%
- Bleeding Disorders: 6 people, 22.22%
- Pain: 4 people, 14.81%
- Asthma: 3 people, 11.11%
- Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 7.41%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 7.41%
- Hypersensitivity: 2 people, 7.41%
* Approximation only. Some reports may have incomplete information.
Do you take Apixaban and Epipen?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Apixaban and Epipen:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Apixaban:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Epipen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Apixaban and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Epipen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on apixaban and epinephrine (the active ingredients of Apixaban and Epipen, respectively), and Apixaban and Epipen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Avapro cause Musculoskeletal Discomfort? - a second ago
- Could Tranxene cause Fluid Retention? - 5 seconds ago
- Androgen Deficiency and Hypotension - 9 seconds ago
- Metastatic Malignant Melanoma and Dyspnea - 9 seconds ago
- Could Losartan Potassium And Hydrochlorothiazide cause Memory Loss? - 11 seconds ago
- Could Tramadol Hydrochloride cause Immunodeficiency? - 16 seconds ago
- Could Lorazepam cause Enterococcal Infection? - 19 seconds ago
- Could Pepcid cause Thyroid Mass? - 30 seconds ago
- Low Density Lipoprotein Increased and High Blood Pressure - 39 seconds ago
- Drug interactions of Aloxi and Emend - 41 seconds ago